×

CellRapeutics™ Leukopak from Hashimoto's Disease Donor (XS-0426-XU241)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Collected from donors with Hashimoto's Thyroiditis, this product provides a concentrated pool of leukocytes involved in the chronic lymphocytic infiltration of the thyroid gland. The cell population features high titers of anti-TPO and anti-TG specific lymphocytes. It is optimized for studying Th1-mediated autoimmune destruction of thyroid follicles and the genetic markers associated with the most common cause of hypothyroidism.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ Leukopak from Hashimoto's Disease Donor
  • Cat. No.
  • XS-0426-XU241
  • Donor Age
  • Middle-Aged
  • Donor Health
  • Donors exhibit chronic thyroiditis. The cell population is characterized by expanded autoreactive lymphocyte clones involved in thyroid tissue destruction and a systemic autoimmune-skewed repertoire.
  • Ethnicity
  • Diverse backgrounds available.
  • Anticoagulant
  • Acid Citrate Dextrose, selected to stabilize thyroid-peroxidase reactive lymphocytes and maintain functional metabolic states.
  • Additional Donor Information
  • Each lot features a Leukopak from donors with chronic lymphocytic thyroiditis. Profiles include anti-TPO and anti-TG antibody status, facilitating research into the lymphocytic infiltration mechanisms of autoimmune hypothyroidism.
  • Clinical Profile
  • Documented TPO antibodies, history of hypothyroidism, and thyroid hormone replacement therapy status.

Additional Information

  • Medication History
  • Available upon request. Primarily documents long-term thyroid hormone replacement therapy and thyroid antibody status.
  • Formulation
  • Cryopreserved or Fresh options available.
  • Cell Purity
  • >90%
  • Cell Viability
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Genetic Stability Testing
  • The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.
  • Storage
  • Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • Full Bag, Half Bag
  • Keywords
  • CellRapeutics™ Leukopak from Hashimoto's Disease Donor, Leukopak, Hashimoto's Disease

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Hashimoto's Disease Donor (XS-0426-XU241). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.